Publications in collaboration with researchers from Hospital Universitario 12 de Octubre (22)

2022

  1. Lactoferrin as Immune-Enhancement Strategy for SARS-CoV-2 Infection in Alzheimer’s Disease Patients

    Frontiers in Immunology, Vol. 13

  2. Multicentric Standardization of Protocols for the Diagnosis of Human Mitochondrial Respiratory Chain Defects

    Antioxidants, Vol. 11, Núm. 4

  3. Low aerobic capacity in McArdle disease: A role for mitochondrial network impairment?

    Molecular metabolism, Vol. 66, pp. 101648

  4. JNK1 and JNK3: divergent functions in hippocampal metabolic-cognitive function

    Molecular Medicine, Vol. 28, Núm. 1

2021

  1. Salivary lactoferrin is associated with cortical amyloid-beta load, cortical integrity, and memory in aging

    Alzheimer's Research and Therapy, Vol. 13, Núm. 1

  2. Neuroplasticity and inflammatory alterations in the nucleus accumbens are corrected after risperidone treatment in a schizophrenia-related developmental model in rats

    Schizophrenia Research, Vol. 235, pp. 17-28

  3. Cohort profile: The Spanish Early-onset Colorectal Cancer (SECOC) cohort: A multicentre cohort study on the molecular basis of colorectal cancer among young individuals in Spain

    BMJ Open, Vol. 11, Núm. 12

2020

  1. Decreased salivary lactoferrin levels are specific to Alzheimer's disease

    Journal of Cleaner Production

2019

  1. Risperidone Ameliorates Prefrontal Cortex Neural Atrophy and Oxidative/Nitrosative Stress in Brain and Peripheral Blood of Rats with Neonatal Ventral Hippocampus Lesion

    The Journal of neuroscience : the official journal of the Society for Neuroscience, Vol. 39, Núm. 43, pp. 8584-8599

2017

  1. Early diagnosis of mild cognitive impairment and Alzheimer's disease based on salivary lactoferrin

    Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring, Vol. 8, pp. 131-138

2016

  1. Secondary coenzyme Q10 deficiencies in oxidative phosphorylation (OXPHOS) and non-OXPHOS disorders

    Mitochondrion, Vol. 30, pp. 51-58

2012

  1. Mortality after surgery in Europe: A 7 day cohort study

    The Lancet, Vol. 380, Núm. 9847, pp. 1059-1065

2009

  1. Coenzyme Q10 deficiency associated with a mitochondrial DNA depletion syndrome: A case report

    Clinical Biochemistry, Vol. 42, Núm. 7-8, pp. 742-745

2008

  1. Hemoperitoneo como forma de presentación del carcinoma hepatocelular: Experiencia de tres casos con rotura tumoral espontánea y revisión de la literatura

    Anales de Medicina Interna, Vol. 25, Núm. 2, pp. 81-84

2005

  1. Estudio multicéntrico de incidencia de las complicaciones de la nutrición parenteral total en el paciente grave. Estudio ICOMEP 1 a parte

    Nutricion Hospitalaria, Vol. 20, Núm. 4, pp. 268-277

  2. Estudio multicéntrico de incidencia de las complicaciones de la nutrición enteral total en el paciente grave. Estudio ICOMEP 2 a parte

    Nutricion Hospitalaria, Vol. 20, Núm. 4, pp. 278-285

2003

  1. Reactive oxygen species mediate the down-regulation of mitochondrial transcripts and proteins by tumour necrosis factor-α in L929 cells

    Biochemical Journal, Vol. 370, Núm. 2, pp. 609-619

2000

  1. Tumor necrosis factor-α increases the steady-state reduction of cytochrome b of the mitochondrial respiratory chain in metabolically inhibited L929 cells

    Journal of Biological Chemistry, Vol. 275, Núm. 18, pp. 13353-13361

1997

  1. Tumor necrosis factor-α increases ATP content in metabolically inhibited L929 cells preceding cell death

    Journal of Biological Chemistry, Vol. 272, Núm. 48, pp. 30167-30177

  2. Tumor necrosis factor α inhibits collagen α1(I) gene expression in rat hepatic stellate cells through a G protein

    Gastroenterology, Vol. 113, Núm. 2, pp. 625-640